PS Ratio
70.62
-2.28-3.13%
3 min ago
Summary
- As of February 12, 2025, XFOR price to sales ratio is 70.62, with a fall of -2.28 (-3.13%) during the most recent trading day.
- XFOR PS ratio is now -73.14% below its all-time high of 262.87.
Performance
XFOR PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
XFOR PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -3.1% | -3.1% | -3.1% | +99.5% |
| 1 m1 month | -18.4% | -18.4% | -18.4% | - |
| 3 m3 months | -23.1% | -23.1% | -23.1% | +99.5% |
| 6 m6 months | -62.9% | -26.9% | -26.0% | - |
| ytdytd | -37.4% | -37.4% | -37.4% | - |
| 1 y1 year | - | -55.3% | -54.5% | +99.5% |
| 5 y5 years | - | -94.9% | -46.0% | - |
XFOR PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -45.3% | 70.62 | at low | |
| 3 m | 3-month | 129.10 | -45.3% | 46.40 | +52.2% |
| 6 m | 6-month | 233.42 | -69.8% | 46.40 | +52.2% |
| 1 y | 1-year | 262.87 | -73.1% | 46.40 | +52.2% |
| 3 y | 3-year | 262.87 | -73.1% | 46.40 | +52.2% |
| 5 y | 5-year | 262.87 | -73.1% | 42.94 | +64.5% |
| alltime | all time | 262.87 | -73.1% | 9.66 | +631.1% |
X4 Pharmaceuticals PS Ratio History
| Date | Value |
|---|---|
| 2025 | 70.62(-37.4%) |
| Date | Value |
|---|---|
| 2024 | 112.73(+1067.0%) |
| 2018 | 9.66 |
FAQ
- What is X4 Pharmaceuticals price to sales ratio?
- What is the all time high PS ratio for X4 Pharmaceuticals?
- What is XFOR price to sales ratio year-to-date change?
What is X4 Pharmaceuticals price to sales ratio?
The current PS ratio of XFOR is 70.62
What is the all time high PS ratio for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high price to sales ratio is 262.87
What is XFOR price to sales ratio year-to-date change?
X4 Pharmaceuticals price to sales ratio has changed by -42.11 (-37.35%) since the beginning of the year